<DOC>
	<DOCNO>NCT01089309</DOCNO>
	<brief_summary>The present study investigate long-term ( 12 month ) effect spironolactone treatment glucose homeostasis , metabolic parameter vascular property .</brief_summary>
	<brief_title>Effect Aldosterone Blockade Arterial Compliance</brief_title>
	<detailed_description />
	<mesh_term>Spironolactone</mesh_term>
	<criteria>1. patient type 2 diabetes mellitus 1. history unstable angina , myocardial infarction ( MI ) , cerebrovascular accident ( CVA ) 2. major surgery within six month precede entrance study 3. unbalanced endocrine disease 4. disease might affect absorption medication 5. plasma creatinine &gt; 2.5 mg/dl 6. elevation liver enzymes twice upper normal limit 7. plasma potassium level &gt; 5.5 mg/dl</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Aldosterone Blockade</keyword>
	<keyword>Arterial elasticity</keyword>
	<keyword>Glycemic control</keyword>
</DOC>